ROLE OF ROSUVASTATIN PRETREATMENT IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY

Authors

  • Ahmed Abdul-Aziz ElTahawy
  • Basem Elsaid Enany
  • Mohsen Fahmy

DOI:

https://doi.org/10.47144/phj.v46i4.704

Keywords:

Contrast Induced Nephropathy, Rosuvastatin, Angiography

Abstract

Objective: The aim of this study was to assess the efficacy of short-term highdose
rosuvastatin pretreatment therapy for the prevention of contrast induced
nephropathy.
Methodology: This study prospectively included two hundred patients who
underwent coronary angiography, and were randomized into two groups: control
group (included 100 patients who did not receive statin therapy) and statin group
(included 100 patients who received rosuvastatin 20 mg/day 3 days before and 7
days after coronary angiography).According to recommendations of the National
kidney foundation, results had been recorded using both serum creatinine and
glomular filteration rate levels.
Results: There was statistically significant reduction in the occurrence of
contrast-induced nephropathy in rosuvastatin pretreated patients ("22%" and
"15%" of them developed contrast-induced nephropathy regarding the glomular
filteration rate and serum creatinine levels respectively), compared to those in the
control group ("35%" and "38%" regarding the glomular filteration rate and serum
creatinine levels respectively) with P-value (<0.001 regarding serum creatinine
and <0.042 regarding glomular filteration rate).
Conclusion: This study favors statin pretreatment for preventing contrast
induced nephropathy in patients undergoing coronary angiography.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
ElTahawy AA-A, Enany BE, Fahmy M. ROLE OF ROSUVASTATIN PRETREATMENT IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY. Pak Heart J [Internet]. 2014May15 [cited 2024Nov.23];46(4). Available from: https://pakheartjournal.com/index.php/pk/article/view/704

Issue

Vol. 46 No. 4 (2013): Pakistan Heart Journal

Section

Original Article

License

When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.

Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/